What is the disease? Muscle fiber Depending on the inheritance pattern, there are sex chromosomal recessive Duchenne type (severe type), Becker type (benign type), and autosomal recessive What is the cause?It is a genetic abnormality. The causative gene is often an abnormality in a protein that constitutes a structure related to the mutual adhesion between the plasma membrane on the surface of skeletal muscle fibers and the basement membrane that surrounds it, such as dystrophin. Below, we will explain the typical Duchenne type. This type is inherited through sex chromosome recessive inheritance and affects boys, with an incidence rate of 1 in 3,500 male births. How symptoms manifestThere are no obvious symptoms in infancy, and the child does not begin to walk significantly later. Usually, symptoms become noticeable around the age of 3 to 5 when the child begins to fall easily or is unable to run. Muscle weakness is most prevalent in the proximal muscles of the limbs (the muscles close to the trunk of the thighs and upper arms), and Pseudohypertrophy is seen in the calf of the lower leg. Pseudohypertrophy is not muscle, but is caused by an increase in fat and connective tissue, which makes the calf thicker. Many children become unable to walk by age 8 to 10, but muscle strength is relatively preserved in the distal muscles of the limbs (muscles far from the trunk in the lower legs and forearms). Muscle atrophy becomes more pronounced in the trunk and proximal muscles of the limbs. After puberty, muscle weakness progresses, and the patient is unable to move anything except for the fingertips, requiring full assistance in daily life. Testing and diagnosisBlood tests show elevated levels of creatine kinase, a muscle enzyme. Electromyograms show myogenic changes. Muscle biopsies show histological changes, with repeated necrosis and regeneration of muscle fibers. The definitive diagnosis is made by genetic testing to confirm a deletion of the dystrophin gene. Treatment methodsDrug therapy, gene therapy, and stem cell transplantation are being researched as fundamental treatments, but they are not yet at the stage of practical application. At this time, it is important to perform appropriate rehabilitation and prevent complications. Rehabilitation should be performed according to the progression of symptoms, walking should be continued as much as possible, stability in standing and sitting positions and respiratory function should be maintained, and environmental improvements should be made to improve the patient's quality of life. The main treatment for complications is management of cardiac and respiratory failure. With the widespread use of artificial ventilators, the number of deaths from respiratory failure has dropped dramatically, but the number of deaths from heart failure is increasing, and the average life expectancy remains short at 30 years. What to do if you notice an illnessFirst, please visit a nearby pediatrician. After a diagnosis, ask them to introduce you to a specialized facility with an attached school that can treat children with the same disease, and consider sending your child to school. Masashi Fujii Source: Houken “Sixth Edition Family Medicine Encyclopedia” Information about the Sixth Edition Family Medicine Encyclopedia |
どんな病気か 筋線維の 遺伝形式により、性染色体劣性遺伝のデュシェンヌ型(重症型)、ベッカー型(良性型)、常染色体劣性遺伝の 原因は何か遺伝子の異常です。原因遺伝子は、ジストロフィンなどのように骨格筋の筋線維表面の形質膜と、それを取り巻く基底膜との相互の接着に関係する構造体を構成する蛋白の異常症である場合が多くみられます。 以下、代表的なデュシェンヌ型について述べます。この型の遺伝形式は性染色体劣性遺伝で、男児に発症し、発生率は出生男児3500人に1人です。 症状の現れ方乳児期には明らかな症状はみられず、歩き始める時期が大きく遅れることはありません。通常、3~5歳ころに転びやすい、走れないなどの異常で気づきます。 筋力低下は、四肢近位筋(大腿や上腕の体幹に近い筋肉)に多く、立ち上がる時に一度 下腿のふくらはぎに仮性肥大がみられます。仮性肥大は筋肉ではなく、脂肪や結合織が増えて太くなります。 多くは8~10歳で歩行不能となりますが、四肢遠位筋(下腿や前腕の体幹から遠い筋肉)は筋力が比較的保たれます。筋萎縮は、体幹や四肢近位筋に著しくなってきます。 思春期以降になると筋力低下が進行し、指先以外はほとんど動かなくなって日常生活に全介助が必要になります。咽喉頭筋の筋力低下で経管栄養や 検査と診断血液検査では、筋の逸脱酵素であるクレアチンキナーゼの値が高値を示します。筋電図では筋原性変化を認めます。筋生検では、筋線維の壊死・再生が繰り返されている組織像の変化を認めます。 確定診断は、遺伝子検査でジストロフィン遺伝子の欠失を確認して行います。 治療の方法根本的治療法として薬物療法、遺伝子治療、幹細胞移植治療などが研究されていますが、まだ実用化の段階ではありません。 現時点では、適切なリハビリテーションと合併症の予防を行うことが大切です。症状の進行に合わせてリハビリテーションを行い、できる限り歩行を継続し、起立・坐位の安定と呼吸機能の維持を図り、環境整備を行ってQOLの向上を目指します。合併症の治療としては心不全、呼吸不全の管理が中心になります。 人工呼吸器の普及により、呼吸不全で死亡する例が激減していますが、心不全で死亡する例が増加しているので、平均寿命は30歳と依然として短いのが現状です。 病気に気づいたらどうするまず、近くの小児科を受診してください。診断後は、同じ病気をもつ子どもに対応ができる学校が併設されている専門施設を紹介してもらい、通学することを検討してください。 藤井 正司 出典 法研「六訂版 家庭医学大全科」六訂版 家庭医学大全科について 情報 |
<<: Population policy - jinkouseisaku (English spelling) population policy
1. Small pickled fish such as sardines and gizzard...
A clan of lower-ranking military officers of the n...
…Downstream, it is navigable for about 130 km. Ci...
…A river that flows north through central Europe....
Human actions are performed in the hope of receivi...
Ink for creating a magnetic recording layer by pri...
A city in southeastern Hokkaido. Established as a ...
1557-1620 Oda-Toyotomi - A military commander and...
An annual dragon boat race held in the Nagasaki re...
In addition to the above drawings, architectural ...
A town in the province of Turin in the Piedmont re...
…A career soldier from the state of Mato Grosso w...
…Several yearly gyoji were in charge of the town ...
…The palace of Cardinal Ippolito II d'Este (1...
...In Okinawa, the mainland is called 'jamatu...